IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice.
Harley IT, Stankiewicz TE, Giles DA, Softic S, Flick LM, Cappelletti M, Sheridan R, Xanthakos SA, Steinbrecher KA, Sartor RB, Kohli R, Karp CL, Divanovic S.
Harley IT, et al. Among authors: softic s.
Hepatology. 2014 May;59(5):1830-9. doi: 10.1002/hep.26746. Epub 2014 Mar 27.
Hepatology. 2014.
PMID: 24115079
Free PMC article.